Tetavax
Purified tetanus toxoid vaccine · Sanofi Pasteur
Prevents
Dosing schedules
Unvaccinated people: 3 primary doses, booster every 10 years
For: Adults (18–59 years)
| Dose | Age | Minimum interval from previous dose |
|---|---|---|
| Dose 1 (Tetavax) | People not vaccinated against tetanus | – |
| Dose 2 (Tetavax) | 1–2 months after dose 1 | 30 days |
| Dose 3 (Tetavax) | 6–12 months after dose 2 | 180 days |
| Booster (Tetavax) Booster | Every 10 years | 3650 days Booster every 10 years |
Prophylaxis after a wound according to the treatment protocol (p. 156), as prescribed by a health worker.
Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition).
Pregnant women without 3 primary doses or with unknown history (EPI)
For: Women planning pregnancy or pregnant
| Dose | Age | Minimum interval from previous dose |
|---|---|---|
| Dose 1 (tetanus) | Early in pregnancy | – |
| Dose 2 (tetanus) | At least 1 month after dose 1 and at least 2 weeks before the expected delivery date | 30 days |
| Dose 3 (tetanus) | In the next pregnancy, at least 6 months after dose 2 | 180 days |
| Dose 4 (tetanus) | In the next pregnancy, at least 1 year after dose 3 | 365 days |
| Dose 5 (tetanus) | In the next pregnancy, at least 1 year after dose 4 | 365 days |
Under Decision 94/QD-PB (section 5): (1) not vaccinated, fewer than 3 primary doses before age 1, or unknown history: 5 doses as in this regimen; (2) 3 primary doses completed: dose 1 early in pregnancy, dose 2 at least 1 month later, dose 3 in the next pregnancy and at least 1 year after dose 2; (3) 3 primary doses and 1 booster: dose 1 early in pregnancy, dose 2 in the next pregnancy and at least 1 year later; (4) 3 primary doses and 2 boosters: a single dose early in pregnancy. In every situation: the last dose at least 2 weeks before the expected due date.
Source: EPI schedule under Decision 94/QD-PB of 30/6/2026 of the Department of Disease Prevention (in force from 01/7/2026), Appendix I (94/QĐ-PB).
Special precautions
Primary schedule of 3 doses; also used for tetanus prophylaxis after a tetanus-prone wound.
Pregnancy and breastfeeding
Indicated to protect pregnant women and prevent neonatal tetanus